Project CHRYSANTHEMUM

The Spartan-IIIs underwent bio-enhancement procedures similar to those of the Spartan-II's. The procedures were referred to as Project CHRYSANTHEMUM. With advances in technology, however, the survival rate for Spartan-III candidates was usually 100%, as opposed to the 44% survival rate of the Spartan-IIs. The Spartan-IIIs were injected with the following augmentation drugs:

• Drug 8942-LQ99: A carbide ceramic ossification catalyst to make skeletons virtually unbreakable.
• Drug 88005-MX77: A fibroid muscular protein complex that boosted muscle density and strength.
• Drug 88947-OP24: A retina-inversion stabilizer drug. It boosted color and night vision capabilities.
• Drug 87556-UD61: Improved colloidal neural disunification solution, which in turn decreases reaction time.

In addition, the following drugs were injected into the Spartans of Gamma Company. They were illegal, but Kurt-051 felt that they were necessary for the Spartans to survive.

• Drug 009762-OO: A mutagen that alters key regions of the subject's frontal lobe. Enhances aggression, strength, endurance, and tolerance to injury. Kept in check by the antipsychotic and bipolar-integration drugs.
• Drug 009927-DG: miso-olanzapine. An antipsychotic. Counters the mutagen's properties.
• Drug 009127-PX: cyclodexione-4. A bipolar-integration drug. Counters the mutagen's properties.